1. Home
  2. PTGX vs PCH Comparison

PTGX vs PCH Comparison

Compare PTGX & PCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTGX
  • PCH
  • Stock Information
  • Founded
  • PTGX 2006
  • PCH 1903
  • Country
  • PTGX United States
  • PCH United States
  • Employees
  • PTGX N/A
  • PCH N/A
  • Industry
  • PTGX Biotechnology: Pharmaceutical Preparations
  • PCH Real Estate Investment Trusts
  • Sector
  • PTGX Health Care
  • PCH Real Estate
  • Exchange
  • PTGX Nasdaq
  • PCH Nasdaq
  • Market Cap
  • PTGX 3.3B
  • PCH 3.2B
  • IPO Year
  • PTGX 2016
  • PCH N/A
  • Fundamental
  • Price
  • PTGX $51.07
  • PCH $42.75
  • Analyst Decision
  • PTGX Strong Buy
  • PCH Strong Buy
  • Analyst Count
  • PTGX 8
  • PCH 7
  • Target Price
  • PTGX $70.13
  • PCH $49.86
  • AVG Volume (30 Days)
  • PTGX 608.4K
  • PCH 600.1K
  • Earning Date
  • PTGX 08-06-2025
  • PCH 07-28-2025
  • Dividend Yield
  • PTGX N/A
  • PCH 4.18%
  • EPS Growth
  • PTGX N/A
  • PCH 15.06
  • EPS
  • PTGX 0.80
  • PCH 0.53
  • Revenue
  • PTGX $209,180,000.00
  • PCH $1,056,523,000.00
  • Revenue This Year
  • PTGX N/A
  • PCH $1.69
  • Revenue Next Year
  • PTGX $53.09
  • PCH $5.46
  • P/E Ratio
  • PTGX $63.42
  • PCH $81.28
  • Revenue Growth
  • PTGX N/A
  • PCH N/A
  • 52 Week Low
  • PTGX $33.31
  • PCH $36.82
  • 52 Week High
  • PTGX $60.60
  • PCH $48.12
  • Technical
  • Relative Strength Index (RSI)
  • PTGX 37.60
  • PCH 58.60
  • Support Level
  • PTGX $52.03
  • PCH $40.63
  • Resistance Level
  • PTGX $54.81
  • PCH $43.62
  • Average True Range (ATR)
  • PTGX 2.11
  • PCH 1.24
  • MACD
  • PTGX -0.52
  • PCH 0.12
  • Stochastic Oscillator
  • PTGX 8.78
  • PCH 69.91

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

About PCH PotlatchDeltic Corporation

PotlatchDeltic Corp is a REIT that owns and manages forestland in Alabama, Arkansas, Idaho, Minnesota, and Mississippi. Potlach operates in three segments. The timberlands segment covers the planting and harvesting of trees, as well as the construction and maintenance of roads. The wood products segment manufactures and distributes lumber, plywood, and other wood products. The real estate segment covers the sales generated from company-owned timberlands, as well as commercial and residential properties. The timberlands and the wood product segments combined drive the majority of the company's revenue.

Share on Social Networks: